Ligand validation:5M18

MUR: beta-muramic acid

MUR is a Ligand Of Interest in 5M18 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5M18_MUR_A_703	11%	21%	0.315	0.832	1.66	1.63	2	4	5	0	100%	1
5M18_MUR_B_702	8%	17%	0.331	0.811	1.5	2.1	2	6	7	0	100%	1
5M19_MUR_A_703	18%	6%	0.279	0.87	1.68	3.33	4	8	10	0	100%	1
4CPK_MUR_B_1677	15%	8%	0.269	0.832	1.07	3.44	2	10	11	0	100%	1
5M1A_MUR_B_703	14%	18%	0.266	0.814	1.6	1.91	4	7	7	0	100%	1
3ZFZ_MUR_A_1670	13%	21%	0.3	0.839	1.41	1.92	3	8	3	0	100%	1
3ZG0_MUR_A_1677	6%	15%	0.381	0.817	1.36	2.35	2	5	2	0	100%	1
1LOD_MUR_A_230	62%	2%	0.123	0.916	3.53	3.21	5	11	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.